News & Updates
Filter by Specialty:
Simplified, tailored treatment for asthma improves patient outcomes
Asthma is a highly prevalent disease that can affect anybody regardless of age, race, and location. The overall burden of asthma remains severe. Despite the range of available therapies and well-established guidelines, there remains a significant unmet need in the management of asthma. [BMC Public Health 2012;12:860; Respir Res 2023;24:169; Eur Respir J 2014;43:343-373]
Simplified, tailored treatment for asthma improves patient outcomes
29 Nov 2023
COVID-19 infection ups CV risk in people living with HIV
People living with HIV (PLWH) who were diagnosed with COVID-19 had a 35-percent higher risk of a major cardiovascular (CV) event in the following year than PLWH without COVID in a Spanish study.
COVID-19 infection ups CV risk in people living with HIV
29 Nov 2023
Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS
In the CONFIDENT trial, convalescent plasma (CCP) conferred a mortality benefit for patients with COVID-19-induced acute respiratory distress syndrome (ARDS) who were on invasive mechanical ventilation (IMV).
Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS
28 Nov 2023
BOREAS highlights dupilumab potential in COPD
In the phase III BOREAS trial, the monoclonal antibody dupilumab conferred multiple benefits for individuals with chronic obstructive pulmonary disease (COPD) and type 2 (T2) inflammation.
BOREAS highlights dupilumab potential in COPD
27 Nov 2023
Which factors predict pulmonary hypertension in ILD?
Multiple risk factors for pulmonary hypertension such as age, sex, and weight, among others, do not appear to influence the severity of interstitial lung disease (ILD), according to a recent study presented at APSR 2023.